LabCentral

It's here! The first full episode of our new video series, 'The Dish with Johannes' is out on our Youtube channel! 🧫🔬 Full episode here 👉 https://lnkd.in/eTgUHdfd In our premiere episode, Johannes Fruehauf sits down with Katrine Bosley to hear more about her latest startup venture – DaCapo Brainscience. Katrine makes up a small number of #innovative serial #biotech entrepreneurs that call LabCentral home, making her insight invaluable to the first time #founder. Head to our YouTube channel to watch the full episode of 'The Dish with Johannes' and let us know what you think!

Are you missing out on your next funding opportunity? 🤔 In our latest episode of The Dish, Jack Silberstein tells Johannes Fruehauf how he landed $50,000 of funding for space at LabCentral through the Servier Golden Ticket contest – after applying 'on a whim' . Watch the full episode on our YouTube channel to learn more about the different ways Jack leverages the community to kickstart his #stealthmode startup! 📈 You can catch the full episode here: https://bit.ly/4b6iNTC

ART RECEPTION ALERT! 🎨 #Gallery1832 is thrilled to present our next art reception, 'Out of Square'! Featured artist Nygel Jones brings to life a unique fusion of industrial design, pop culture, and craftsmanship, drawing from his experiences in custom fabrication and woodworking. This exhibit celebrates the interconnectedness of form and function, bringing viewers into the world of industrial aesthetics with a twist of nostalgic creativity. Come explore how spontaneous design meets calculated craftsmanship! 📅 Thursday, February 27th ⏰ 4:30pm - 7:30pm 📍 238 Main St. RSVP: https://lnkd.in/e3Esy-ub As always, this event is free and open to the public. See you there!

We are excited to announce our new #partnership with Ajinomoto Group Innovation Strategy Development North America! 🎉 The Ajinomoto Group aims to contribute to the well-being of all human beings, our society, and our planet with “AminoScience” and its cutting-edge technologies, including #innovations in cell and gene therapy, amino acid, and protein sciences. The Ajinomoto Innovation Strategy Development Team in particular is fully committed to supporting the thriving #biotech ecosystem in Cambridge and Massachusetts. We're proud to collaborate together and look forward to fostering scientific #breakthroughs and strengthening our life sciences network! 👇 👇 👇 Read the full press release below 👇 👇 👇

In honor of Black History Month, join us next Wednesday for a powerful discussion on the lasting impact of the black community in health and medicine. From groundbreaking discoveries to the enduring legacy of HeLa cells, their contributions have shaped the future of scientific research. 📅 February 13th ⏰ 4:30PM - 7PM 📍 700 Main St. We'll also explore pressing health challenges, including the continued disparity in healthcare access and diseases that disproportionately affect the black community. Through conversations with patients, experts, and other community members, we'll look at forging a path toward a more equitable healthcare future. Don't miss this opportunity to engage, learn, and be inspired. RSVP at the link below 👇 👇 https://lnkd.in/eENqzftr

It's time to Dish!! 🧫🔬 The latest full episode of our video series, 'The Dish' just dropped on our YouTube channel! Full episode here 👉 https://lnkd.in/dYdkj8_T In this episode, Johannes Fruehauf sits down with Jack Silberstein to discuss his journey to Boston and how he's managed to successfully fundraise a stealth mode company in the current #biotech climate! 🤑 Listen in to learn about how networking, taking risks, and prioritizing talent can help take your #biotechstartup's mission to the next level. 📈

How do you approach the FDA when patient safety and access are at stake? 🤔 In our recent epsiode of #TheDish, Elan Weiner shares how early alignment between ECI Therapeutics and the FDA has been critical to their strategy—ensuring patient safety while streamlining the path to approval. ✅ Learn how #collaboration with regulatory agencies can pave the way for faster, smarter #biotech #innovation. 👇👇Catch the full conversation now! 👇👇 https://lnkd.in/e9AaRjSv

Check out this cool feature on GreenLabs Recycling in the Boston Globe Media! Through our partnership with GreenLabs, they've helped recycle thousands of pounds of #pipette tips over the years! Their initiatives at LabCentral left a lasting impact on our resident #scientists interested in #sustainable lab practices. 👇👇 Read more about how their impact is expanding. 👇 👇

🎟 GOLDEN TICKET ALERT 🎟 Daiichi Sankyo US is now accepting applications to their 2025 Golden Ticket Contest. The recipient of the #GoldenTicket will receive a $50,000 credit towards space & services at our flagship site at 700 Main Street in Cambridge. Additionally, recipients will have access to Daiichi Sankyo US's team of skilled experts for guidance and feedback to early-stage companies. Applications are especially encouraged for startups developing innovative technologies and therapies in the following areas: #Modality & #Technology, #Oncology, and #SpecialtyMedicine. If you're a #biotechstartup looking to jumpstart your research at LabCentral, apply by February 28th! Head to the link below to learn more 👇 👇 https://lnkd.in/eMjxR5zF

What happens when a surgeon’s biggest tool gets taken away? 🚨 In our latest episode of The Dish, Elan Weiner tells host, Johannes Fruehauf, about ECI Therapeutics's fascinating journey of creating a pharmaceutical-grade product inspired by unmet needs in #ophthalmology. From #plasma-derived treatments to addressing critical gaps in FDA approval, their story is the perfect example of #innovation in action. 🎥 Catch the full story on our YouTube channel 🎥 https://lnkd.in/e9AaRjSv You can also catch Elan at this week's J.P. Morgan Health Care Conference! To chat with him more, message him on LinkedIn or email elanw@ecitherapeutics.com